Back
NRX Pharmaceuticals Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
43
NRXP
NRX Pharmaceuticals
Last Price:
1.21
Seasonality Move:
39.07%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRXP is experiencing slight selling pressure.
NRX Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Sell |
| 20-day SMA: | 1.28 | Sell |
| 50-day SMA: | 1.42 | Sell |
| 200-day SMA: | 2.9 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.28 | Sell |
| 50-day EMA: | 1.45 | Sell |
| 200-day EMA: | 2.65 | Sell |
NRX Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 41.7 | Sell |
| Chaikin Money Flow: | -33393 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.33) | Sell |
| Bollinger Bands (100): | (1.34 - 2.18) | Sell |
NRX Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NRX Pharmaceuticals Stock
Is NRX Pharmaceuticals Stock a Buy?
- NRX Pharmaceuticals share price is 1.21 while NRXP 8-day simple moving average is 1.23, which is a Sell signal.
- The stock price of NRXP is 1.21 while NRX Pharmaceuticals 20-day SMA is 1.28, which makes it a Sell.
- NRX Pharmaceuticals 50-day simple moving average is 1.42 while NRXP share price is 1.21, making it a Sell technically.
- NRXP stock price is 1.21 and NRX Pharmaceuticals 200-day simple moving average is 2.90, creating a Sell signal.
NRXP Technical Analysis vs Fundamental Analysis
Sell
43
NRX Pharmaceuticals (NRXP)
is a Sell
Is NRX Pharmaceuticals a Buy or a Sell?
-
NRX Pharmaceuticals stock is rated a Sell
The current NRX Pharmaceuticals [NRXP] share price is $1.21. The Score for NRXP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
NRX Pharmaceuticals Stock Info
Market Cap:
14.63M
Price in USD:
1.21
Share Volume:
66.79K
NRX Pharmaceuticals 52-Week Range
52-Week High:
7.33
52-Week Low:
1.10
Sell
43
NRX Pharmaceuticals (NRXP)
is a Sell
NRX Pharmaceuticals Share Price Forecast
-
What is the NRX Pharmaceuticals stock price today?
The NRX Pharmaceuticals stock price is 1.21 USD today. -
Will NRXP stock go up or go down?
NRX Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NRX Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NRX Pharmaceuticals is overvalued.
Is NRX Pharmaceuticals Stock a Buy?
- NRX Pharmaceuticals share price is 1.21 while NRXP 8-day exponential moving average is 1.24, which is a Sell signal.
- The stock price of NRXP is 1.21 while NRX Pharmaceuticals 20-day EMA is 1.28, which makes it a Sell.
- NRX Pharmaceuticals 50-day exponential moving average is 1.45 while NRXP share price is 1.21, making it a Sell technically.
- NRXP stock price is 1.21 and NRX Pharmaceuticals 200-day simple moving average is 2.65, creating a Sell signal.
Fundamental Analysis of NRX Pharmaceuticals
Is NRX Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $1.17 per share.
Technical Analysis of NRX Pharmaceuticals
Should I short NRX Pharmaceuticals stock?
- NRXP Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting NRX Pharmaceuticals is a Sell
- NRX Pharmaceuticals Relative Strength Index (RSI) is 41.7, which suggest NRX Pharmaceuticals is oversold
- The Bollinger Bands (25) for NRX Pharmaceuticals is (1.21 - 1.33), which suggest NRX Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NRX Pharmaceuticals is (1.34 - 2.18), which suggest NRX Pharmaceuticals is a Sell
* NRX Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.